Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy.
about
Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell LymphomaLimited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.Surveillance Scans in Lymphoma: Friend or Foe?Adding weight to a sinking ship: more reasons not to perform routine surveillance imaging in patients with diffuse large B-cell lymphoma in remission.Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma.Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
P2860
Q34402503-98E06FFF-8BE2-4B69-AA7B-D7AC7C651156Q35855599-6EFC8811-C9D1-49D2-80ED-7A5BFFEBF363Q37040596-638FD728-86C3-48D6-B77B-3FCA00C8732CQ38184954-7EB0543A-4A18-4097-B575-1BAA4B4849D2Q38794783-68854F34-91FC-4597-857C-0C117BD3988DQ39036785-406BF8FF-FB17-4FD5-BA76-33D31D6E4F1FQ39142301-BC7686FF-67BC-4322-91C0-C4D9E15F05C9Q47189782-25E5F140-0488-4AB9-BA6F-BD09E744A5E2Q53083174-D58E94D3-8699-4DF1-9894-5C51644CD639Q53120165-FD0346EF-4963-4C0F-A4B6-8954D76D3919
P2860
Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Risk-adapted FDG-PET/CT-based ...... homa after first-line therapy.
@en
Risk-adapted FDG-PET/CT-based ...... homa after first-line therapy.
@nl
type
label
Risk-adapted FDG-PET/CT-based ...... homa after first-line therapy.
@en
Risk-adapted FDG-PET/CT-based ...... homa after first-line therapy.
@nl
prefLabel
Risk-adapted FDG-PET/CT-based ...... homa after first-line therapy.
@en
Risk-adapted FDG-PET/CT-based ...... homa after first-line therapy.
@nl
P2093
P356
P1433
P1476
Risk-adapted FDG-PET/CT-based ...... phoma after first-line therapy
@en
P2093
P Veit-Haibach
U Petrausch
P304
P356
10.1093/ANNONC/MDQ015
P577
2010-02-05T00:00:00Z